José Leal joined the Health Economics Research Centre in January 2004, having completed his MSc in Health Economics at the University of York in 2003. Since joining HERC, José has worked on several projects, including an economic evaluation of genetic testing for sudden cardiac death, an economic evaluation of MS/MS screening for Medium Chain Acyl-CoenzymeA Dehydrogenase Deficiency, elicitation of expert opinion and several cost-of-illness studies.
José has recently completed a doctoral thesis at the University of Oxford on the use of multi-parameter evidence synthesis to inform economic evaluations. His current research interests include the use of expert opinion to inform decision models, evidence synthesis frameworks in economic evaluation and individual patient level modelling.
Accurately reflecting uncertainty when using patient-level simulation models to extrapolate clinical trial data
DAKIN H. et al, (2020), Medical Decision Making
Enhanced recovery following hip and knee arthroplasty: A systematic review of cost-effectiveness evidence
Pritchard M. et al, (2020), BMJ Open
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Reed SD. et al, (2020), Diabetes Care, dc190950 - dc190950
The impact of the enhanced recovery pathway and other factors on outcomes and costs following hip and knee replacement: routine data study
Judge A. et al, (2020), Health Services and Delivery Research, 8, 1 - 188
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaine
KNIGHT R. et al, (2019), Trials